Huilin Ma

837 total citations
27 papers, 625 citations indexed

About

Huilin Ma is a scholar working on Molecular Biology, Oncology and Molecular Medicine. According to data from OpenAlex, Huilin Ma has authored 27 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Molecular Medicine. Recurrent topics in Huilin Ma's work include CAR-T cell therapy research (4 papers), Advanced Battery Materials and Technologies (4 papers) and Lipid Membrane Structure and Behavior (4 papers). Huilin Ma is often cited by papers focused on CAR-T cell therapy research (4 papers), Advanced Battery Materials and Technologies (4 papers) and Lipid Membrane Structure and Behavior (4 papers). Huilin Ma collaborates with scholars based in United States, China and Iran. Huilin Ma's co-authors include Shikha Nangia, Samir Mitragotri, Eden E. L. Tanner, Kelly N. Ibsen, Aleksander S. Popel, Hanwen Wang, Richard J. Sové, Amrita Banerjee, Wenjuan Jiang and Flaviyan Jerome Irudayanathan and has published in prestigious journals such as Nature Communications, Applied and Environmental Microbiology and The Journal of Physical Chemistry B.

In The Last Decade

Huilin Ma

27 papers receiving 619 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huilin Ma United States 14 195 123 89 71 68 27 625
Wu Wang China 18 111 0.6× 98 0.8× 49 0.6× 62 0.9× 23 0.3× 48 745
Fuling Zhou China 15 109 0.6× 74 0.6× 101 1.1× 110 1.5× 53 0.8× 38 682
Chan Wang China 17 227 1.2× 47 0.4× 64 0.7× 44 0.6× 44 0.6× 61 781
Yuqi Guo China 24 589 3.0× 120 1.0× 65 0.7× 156 2.2× 82 1.2× 51 1.2k
Chang Min Kim South Korea 17 203 1.0× 65 0.5× 26 0.3× 65 0.9× 151 2.2× 66 844
Jean‐Christophe Garrigues France 17 367 1.9× 182 1.5× 13 0.1× 115 1.6× 71 1.0× 46 1.1k
Jingxue Wang China 15 342 1.8× 62 0.5× 43 0.5× 73 1.0× 72 1.1× 39 1.2k
Sanjiv Sonkaria South Korea 11 217 1.1× 18 0.1× 73 0.8× 117 1.6× 90 1.3× 26 659
Yao Peng China 22 466 2.4× 114 0.9× 106 1.2× 188 2.6× 60 0.9× 74 1.1k
Somin Lee South Korea 14 251 1.3× 33 0.3× 102 1.1× 106 1.5× 52 0.8× 31 701

Countries citing papers authored by Huilin Ma

Since Specialization
Citations

This map shows the geographic impact of Huilin Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huilin Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huilin Ma more than expected).

Fields of papers citing papers by Huilin Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huilin Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huilin Ma. The network helps show where Huilin Ma may publish in the future.

Co-authorship network of co-authors of Huilin Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Huilin Ma. A scholar is included among the top collaborators of Huilin Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huilin Ma. Huilin Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Y., Huilin Ma, Huan Shi, et al.. (2025). Dextran sulfate-coated curcumin nanocrystals for the treatment of DSS-induced ulcerative colitis in mice. International Journal of Pharmaceutics. 674. 125428–125428. 2 indexed citations
2.
Wang, Jiao, Huilin Ma, Fangjie Yan, et al.. (2025). JOSD2 promotes breast cancer metastasis by deubiquitinating and stabilizing SMAD4. Biochemical Pharmacology. 232. 116748–116748. 1 indexed citations
3.
Shi, Huan, Zhiwei Shi, Huilin Ma, et al.. (2025). Paclitaxel-Ang-2-functionalized bionic mesoporous selenium nanoparticles for targeted therapy of glioma. Pharmacological Research. 216. 107783–107783. 1 indexed citations
4.
Ma, Huilin, et al.. (2025). Berberine‑calcium alginate-coated macrophage membrane-derived nanovesicles for the oral treatment of ulcerative colitis. International Journal of Biological Macromolecules. 294. 139114–139114. 2 indexed citations
5.
Fan, Kexin, Huilin Ma, Tang Wu, et al.. (2024). An insoluble p-type organic polymer cathode with a 9,9′-bicarbazole core for highly stable Li/Na/K-based dual-ion full batteries. Inorganic Chemistry Frontiers. 11(17). 5566–5578. 6 indexed citations
6.
Zhang, Ying, Dongyao Wang, Xiying Wang, et al.. (2024). A dual-target SPR screening system for simultaneous ligand discovery of SARS-CoV-2 spike protein and its receptor ACE2 from Chinese herbs. Journal of Pharmaceutical and Biomedical Analysis. 245. 116142–116142. 7 indexed citations
7.
Li, Wenjun, Huilin Ma, Wu Tang, et al.. (2024). Single organic electrode for multi-system dual-ion symmetric batteries. Nature Communications. 15(1). 9533–9533. 24 indexed citations
8.
Ma, Huilin, et al.. (2024). A Macromolecule Cathode for High-Performance Li-Ion and Na-Ion Batteries. ACS Sustainable Chemistry & Engineering. 12(11). 4576–4586. 3 indexed citations
9.
Wang, Hanwen, Huilin Ma, Richard J. Sové, Leisha A. Emens, & Aleksander S. Popel. (2021). Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer. Journal for ImmunoTherapy of Cancer. 9(2). e002100–e002100. 38 indexed citations
10.
Ma, Huilin, et al.. (2021). Development of the computational antibiotic screening platform (CLASP) to aid in the discovery of new antibiotics. Soft Matter. 17(10). 2725–2736. 5 indexed citations
11.
Ma, Huilin, et al.. (2021). Application oriented bioaugmentation processes: Mechanism, performance improvement and scale-up. Bioresource Technology. 344(Pt B). 126192–126192. 66 indexed citations
12.
Gu, Huan, Tianpeng Gao, Huilin Ma, et al.. (2020). High-Level Antibiotic Tolerance of a Clinically Isolated Enterococcus faecalis Strain. Applied and Environmental Microbiology. 87(1). 6 indexed citations
13.
Sové, Richard J., Mohammad Jafarnejad, Chen Zhao, et al.. (2020). QSP‐IO: A Quantitative Systems Pharmacology Toolbox for Mechanistic Multiscale Modeling for Immuno‐Oncology Applications. CPT Pharmacometrics & Systems Pharmacology. 9(9). 484–497. 43 indexed citations
14.
Ma, Huilin, Hanwen Wang, Richard J. Sové, et al.. (2020). A Quantitative Systems Pharmacology Model of T Cell Engager Applied to Solid Tumor. The AAPS Journal. 22(4). 85–85. 29 indexed citations
15.
Ma, Huilin, et al.. (2020). Interaction of amphiphilic coumarin with DPPC/DPPS lipid bilayer: effects of concentration and alkyl tail length. Physical Chemistry Chemical Physics. 22(27). 15197–15207. 8 indexed citations
16.
Ma, Huilin, et al.. (2020). Quantitative Systems Pharmacology Modeling of PBMC-Humanized Mouse to Facilitate Preclinical Immuno-oncology Drug Development. ACS Pharmacology & Translational Science. 4(1). 213–225. 13 indexed citations
17.
Zhao, Yingxin, Qian Song, Min Ji, et al.. (2019). Volcanic rock‐based ceramsite adsorbent for highly selective fluoride removal: function optimization and mechanism. Journal of Chemical Technology & Biotechnology. 94(7). 2263–2273. 14 indexed citations
18.
Tanner, Eden E. L., et al.. (2019). The Influence of Water on Choline-Based Ionic Liquids. ACS Biomaterials Science & Engineering. 5(7). 3645–3653. 51 indexed citations
19.
Ibsen, Kelly N., Huilin Ma, Amrita Banerjee, et al.. (2018). Mechanism of Antibacterial Activity of Choline-Based Ionic Liquids (CAGE). ACS Biomaterials Science & Engineering. 4(7). 2370–2379. 116 indexed citations
20.
Hu, Pingping, et al.. (2013). Haemoptysis as a prognostic factor in lung adenocarcinoma after curative resection. British Journal of Cancer. 109(6). 1609–1617. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026